UK markets close in 7 hours 58 minutes

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.4600-0.0500 (-1.42%)
At close: 04:00PM EDT
3.5500 +0.09 (+2.60%)
After hours: 06:22PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
95
95
156
114,089
0
Operating expenses
Research development
242,914
242,914
256,387
220,176
192,987
Selling general and administrative
71,673
71,673
79,305
74,105
65,256
Total operating expenses
314,587
314,587
335,692
294,281
258,243
Operating income or loss
-314,492
-314,492
-335,536
-180,192
-258,243
Interest expense
-
-
-
-
0
Total other income/expenses net
-31,080
-31,080
-9,444
-3,573
-67,302
Income before tax
-327,265
-327,265
-340,414
-182,051
-316,381
Income tax expense
-
-
-
0
0
Income from continuing operations
-327,265
-327,265
-340,414
-182,051
-316,381
Net income
-327,265
-327,265
-340,414
-182,051
-316,381
Net income available to common shareholders
-327,265
-327,265
-340,414
-182,051
-316,381
Basic EPS
-2.20
-
-2.38
-1.34
-2.63
Diluted EPS
-2.20
-
-2.38
-1.34
-2.63
Basic average shares
150,856
-
143,147
135,820
120,370
Diluted average shares
150,856
-
143,147
135,820
120,370